FAQs about our Team

From 2008.igem.org

(Difference between revisions)
(New page: <html xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns="http://www.w3.org/TR/REC-html40"> <head> <meta name=Title content="Frequentl...)
Line 1: Line 1:
-
<html xmlns:o="urn:schemas-microsoft-com:office:office"
+
<html xmlns:v="urn:schemas-microsoft-com:vml"
 +
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">
xmlns="http://www.w3.org/TR/REC-html40">
Line 19: Line 20:
   <o:LastAuthor>Andrew Horwitz</o:LastAuthor>
   <o:LastAuthor>Andrew Horwitz</o:LastAuthor>
   <o:Revision>2</o:Revision>
   <o:Revision>2</o:Revision>
-
   <o:Created>2008-10-23T00:09:00Z</o:Created>
+
  <o:TotalTime>0</o:TotalTime>
-
   <o:LastSaved>2008-10-23T00:09:00Z</o:LastSaved>
+
   <o:Created>2008-10-23T00:12:00Z</o:Created>
 +
   <o:LastSaved>2008-10-23T00:12:00Z</o:LastSaved>
   <o:Pages>1</o:Pages>
   <o:Pages>1</o:Pages>
-
   <o:Words>314</o:Words>
+
   <o:Words>315</o:Words>
-
   <o:Characters>1794</o:Characters>
+
   <o:Characters>1801</o:Characters>
   <o:Company>UCSF</o:Company>
   <o:Company>UCSF</o:Company>
-
   <o:Lines>14</o:Lines>
+
   <o:Lines>15</o:Lines>
   <o:Paragraphs>3</o:Paragraphs>
   <o:Paragraphs>3</o:Paragraphs>
-
   <o:CharactersWithSpaces>2203</o:CharactersWithSpaces>
+
   <o:CharactersWithSpaces>2211</o:CharactersWithSpaces>
   <o:Version>11.1280</o:Version>
   <o:Version>11.1280</o:Version>
  </o:DocumentProperties>
  </o:DocumentProperties>
Line 54: Line 56:
{font-family:Arial;
{font-family:Arial;
panose-1:0 2 11 6 4 2 2 2 2 2;
panose-1:0 2 11 6 4 2 2 2 2 2;
-
mso-font-charset:0;
 
-
mso-generic-font-family:auto;
 
-
mso-font-pitch:variable;
 
-
mso-font-signature:50331648 0 0 0 1 0;}
 
-
@font-face
 
-
{font-family:"Lucida Grande";
 
mso-font-charset:0;
mso-font-charset:0;
mso-generic-font-family:auto;
mso-generic-font-family:auto;
Line 70: Line 66:
margin-bottom:.0001pt;
margin-bottom:.0001pt;
mso-pagination:widow-orphan;
mso-pagination:widow-orphan;
 +
font-size:12.0pt;
 +
font-family:"Times New Roman";}
 +
p.MsoListBullet2, li.MsoListBullet2, div.MsoListBullet2
 +
{mso-style-update:auto;
 +
margin-top:0in;
 +
margin-right:0in;
 +
margin-bottom:0in;
 +
margin-left:.5in;
 +
margin-bottom:.0001pt;
 +
text-indent:-.25in;
 +
mso-pagination:widow-orphan;
 +
mso-list:l0 level1 lfo10;
 +
tab-stops:list .5in;
font-size:12.0pt;
font-size:12.0pt;
font-family:"Times New Roman";}
font-family:"Times New Roman";}
Line 86: Line 95:
  /* List Definitions */
  /* List Definitions */
@list l0
@list l0
 +
{mso-list-id:-125;
 +
mso-list-type:simple;
 +
mso-list-template-ids:-1508585756;}
 +
@list l0:level1
 +
{mso-level-number-format:bullet;
 +
mso-level-style-link:"List Bullet 2";
 +
mso-level-text:\F0B7;
 +
mso-level-tab-stop:.5in;
 +
mso-level-number-position:left;
 +
text-indent:-.25in;
 +
font-family:Symbol;}
 +
@list l1
{mso-list-id:52774932;
{mso-list-id:52774932;
mso-list-type:hybrid;
mso-list-type:hybrid;
mso-list-template-ids:989912902 67698703 67698689 67698689 67698703 67698713 67698715 67698703 67698713 67698715;}
mso-list-template-ids:989912902 67698703 67698689 67698689 67698703 67698713 67698715 67698703 67698713 67698715;}
-
@list l0:level1
+
@list l1:level2
-
{mso-level-tab-stop:.5in;
+
-
mso-level-number-position:left;
+
-
text-indent:-.25in;}
+
-
@list l0:level2
+
{mso-level-number-format:bullet;
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-text:\F0B7;
Line 100: Line 117:
text-indent:-.25in;
text-indent:-.25in;
font-family:Symbol;}
font-family:Symbol;}
-
@list l0:level3
+
@list l1:level3
{mso-level-number-format:bullet;
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-text:\F0B7;
Line 108: Line 125:
text-indent:-.25in;
text-indent:-.25in;
font-family:Symbol;}
font-family:Symbol;}
-
@list l0:level4
 
-
{mso-level-tab-stop:2.0in;
 
-
mso-level-number-position:left;
 
-
text-indent:-.25in;}
 
-
@list l1
 
-
{mso-list-id:135687810;
 
-
mso-list-template-ids:1252714396;}
 
-
@list l1:level1
 
-
{mso-level-tab-stop:.5in;
 
-
mso-level-number-position:left;
 
-
text-indent:-.25in;}
 
-
@list l1:level2
 
-
{mso-level-number-format:alpha-lower;
 
-
mso-level-tab-stop:1.0in;
 
-
mso-level-number-position:left;
 
-
text-indent:-.25in;}
 
-
@list l1:level3
 
-
{mso-level-number-format:roman-lower;
 
-
mso-level-tab-stop:1.5in;
 
-
mso-level-number-position:right;
 
-
text-indent:-9.0pt;}
 
-
@list l1:level4
 
-
{mso-level-tab-stop:2.0in;
 
-
mso-level-number-position:left;
 
-
text-indent:-.25in;}
 
-
@list l1:level5
 
-
{mso-level-number-format:alpha-lower;
 
-
mso-level-tab-stop:2.5in;
 
-
mso-level-number-position:left;
 
-
text-indent:-.25in;}
 
-
@list l1:level6
 
-
{mso-level-number-format:roman-lower;
 
-
mso-level-tab-stop:3.0in;
 
-
mso-level-number-position:right;
 
-
text-indent:-9.0pt;}
 
-
@list l1:level7
 
-
{mso-level-tab-stop:3.5in;
 
-
mso-level-number-position:left;
 
-
text-indent:-.25in;}
 
-
@list l1:level8
 
-
{mso-level-number-format:alpha-lower;
 
-
mso-level-tab-stop:4.0in;
 
-
mso-level-number-position:left;
 
-
text-indent:-.25in;}
 
-
@list l1:level9
 
-
{mso-level-number-format:roman-lower;
 
-
mso-level-tab-stop:4.5in;
 
-
mso-level-number-position:right;
 
-
text-indent:-9.0pt;}
 
@list l2
@list l2
{mso-list-id:524756907;
{mso-list-id:524756907;
Line 175: Line 143:
font-family:Symbol;}
font-family:Symbol;}
@list l3
@list l3
-
{mso-list-id:826477724;
 
-
mso-list-template-ids:-2001410642;}
 
-
@list l3:level1
 
-
{mso-level-number-format:roman-lower;
 
-
mso-level-tab-stop:.75in;
 
-
mso-level-number-position:right;
 
-
margin-left:.75in;
 
-
text-indent:-.25in;}
 
-
@list l3:level2
 
-
{mso-level-number-format:alpha-lower;
 
-
mso-level-tab-stop:1.25in;
 
-
mso-level-number-position:left;
 
-
margin-left:1.25in;
 
-
text-indent:-.25in;}
 
-
@list l3:level3
 
-
{mso-level-number-format:roman-lower;
 
-
mso-level-tab-stop:1.75in;
 
-
mso-level-number-position:right;
 
-
margin-left:1.75in;
 
-
text-indent:-9.0pt;}
 
-
@list l3:level4
 
-
{mso-level-tab-stop:2.25in;
 
-
mso-level-number-position:left;
 
-
margin-left:2.25in;
 
-
text-indent:-.25in;}
 
-
@list l3:level5
 
-
{mso-level-number-format:alpha-lower;
 
-
mso-level-tab-stop:2.75in;
 
-
mso-level-number-position:left;
 
-
margin-left:2.75in;
 
-
text-indent:-.25in;}
 
-
@list l3:level6
 
-
{mso-level-number-format:roman-lower;
 
-
mso-level-tab-stop:3.25in;
 
-
mso-level-number-position:right;
 
-
margin-left:3.25in;
 
-
text-indent:-9.0pt;}
 
-
@list l3:level7
 
-
{mso-level-tab-stop:3.75in;
 
-
mso-level-number-position:left;
 
-
margin-left:3.75in;
 
-
text-indent:-.25in;}
 
-
@list l3:level8
 
-
{mso-level-number-format:alpha-lower;
 
-
mso-level-tab-stop:4.25in;
 
-
mso-level-number-position:left;
 
-
margin-left:4.25in;
 
-
text-indent:-.25in;}
 
-
@list l3:level9
 
-
{mso-level-number-format:roman-lower;
 
-
mso-level-tab-stop:4.75in;
 
-
mso-level-number-position:right;
 
-
margin-left:4.75in;
 
-
text-indent:-9.0pt;}
 
-
@list l4
 
-
{mso-list-id:893467802;
 
-
mso-list-template-ids:1991537986;}
 
-
@list l4:level1
 
-
{mso-level-tab-stop:.5in;
 
-
mso-level-number-position:left;
 
-
text-indent:-.25in;}
 
-
@list l4:level2
 
-
{mso-level-number-format:alpha-lower;
 
-
mso-level-tab-stop:1.0in;
 
-
mso-level-number-position:left;
 
-
text-indent:-.25in;}
 
-
@list l4:level3
 
-
{mso-level-number-format:bullet;
 
-
mso-level-text:\F0B7;
 
-
mso-level-tab-stop:117.0pt;
 
-
mso-level-number-position:left;
 
-
margin-left:117.0pt;
 
-
text-indent:-.25in;
 
-
font-family:Symbol;}
 
-
@list l4:level4
 
-
{mso-level-tab-stop:2.0in;
 
-
mso-level-number-position:left;
 
-
text-indent:-.25in;}
 
-
@list l4:level5
 
-
{mso-level-number-format:alpha-lower;
 
-
mso-level-tab-stop:2.5in;
 
-
mso-level-number-position:left;
 
-
text-indent:-.25in;}
 
-
@list l4:level6
 
-
{mso-level-number-format:roman-lower;
 
-
mso-level-tab-stop:3.0in;
 
-
mso-level-number-position:right;
 
-
text-indent:-9.0pt;}
 
-
@list l4:level7
 
-
{mso-level-tab-stop:3.5in;
 
-
mso-level-number-position:left;
 
-
text-indent:-.25in;}
 
-
@list l4:level8
 
-
{mso-level-number-format:alpha-lower;
 
-
mso-level-tab-stop:4.0in;
 
-
mso-level-number-position:left;
 
-
text-indent:-.25in;}
 
-
@list l4:level9
 
-
{mso-level-number-format:roman-lower;
 
-
mso-level-tab-stop:4.5in;
 
-
mso-level-number-position:right;
 
-
text-indent:-9.0pt;}
 
-
@list l5
 
-
{mso-list-id:1225988112;
 
-
mso-list-type:hybrid;
 
-
mso-list-template-ids:-2001410642 67698715 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
 
-
@list l5:level1
 
-
{mso-level-number-format:roman-lower;
 
-
mso-level-tab-stop:.75in;
 
-
mso-level-number-position:right;
 
-
margin-left:.75in;
 
-
text-indent:-.25in;}
 
-
@list l6
 
-
{mso-list-id:1512453927;
 
-
mso-list-template-ids:-2001410642;}
 
-
@list l6:level1
 
-
{mso-level-number-format:roman-lower;
 
-
mso-level-tab-stop:.75in;
 
-
mso-level-number-position:right;
 
-
margin-left:.75in;
 
-
text-indent:-.25in;}
 
-
@list l6:level2
 
-
{mso-level-number-format:alpha-lower;
 
-
mso-level-tab-stop:1.25in;
 
-
mso-level-number-position:left;
 
-
margin-left:1.25in;
 
-
text-indent:-.25in;}
 
-
@list l6:level3
 
-
{mso-level-number-format:roman-lower;
 
-
mso-level-tab-stop:1.75in;
 
-
mso-level-number-position:right;
 
-
margin-left:1.75in;
 
-
text-indent:-9.0pt;}
 
-
@list l6:level4
 
-
{mso-level-tab-stop:2.25in;
 
-
mso-level-number-position:left;
 
-
margin-left:2.25in;
 
-
text-indent:-.25in;}
 
-
@list l6:level5
 
-
{mso-level-number-format:alpha-lower;
 
-
mso-level-tab-stop:2.75in;
 
-
mso-level-number-position:left;
 
-
margin-left:2.75in;
 
-
text-indent:-.25in;}
 
-
@list l6:level6
 
-
{mso-level-number-format:roman-lower;
 
-
mso-level-tab-stop:3.25in;
 
-
mso-level-number-position:right;
 
-
margin-left:3.25in;
 
-
text-indent:-9.0pt;}
 
-
@list l6:level7
 
-
{mso-level-tab-stop:3.75in;
 
-
mso-level-number-position:left;
 
-
margin-left:3.75in;
 
-
text-indent:-.25in;}
 
-
@list l6:level8
 
-
{mso-level-number-format:alpha-lower;
 
-
mso-level-tab-stop:4.25in;
 
-
mso-level-number-position:left;
 
-
margin-left:4.25in;
 
-
text-indent:-.25in;}
 
-
@list l6:level9
 
-
{mso-level-number-format:roman-lower;
 
-
mso-level-tab-stop:4.75in;
 
-
mso-level-number-position:right;
 
-
margin-left:4.75in;
 
-
text-indent:-9.0pt;}
 
-
@list l7
 
{mso-list-id:1669675019;
{mso-list-id:1669675019;
mso-list-type:hybrid;
mso-list-type:hybrid;
mso-list-template-ids:1454386800 67698689 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
mso-list-template-ids:1454386800 67698689 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
-
@list l7:level1
+
@list l3:level1
{mso-level-number-format:bullet;
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-text:\F0B7;
Line 360: Line 160:
-->
-->
</style>
</style>
 +
<!--[if gte mso 9]><xml>
 +
<o:shapedefaults v:ext="edit" spidmax="1027"/>
 +
</xml><![endif]--><!--[if gte mso 9]><xml>
 +
<o:shapelayout v:ext="edit">
 +
  <o:idmap v:ext="edit" data="1"/>
 +
</o:shapelayout></xml><![endif]-->
</head>
</head>
Line 370: Line 176:
is control of gene expression by chromatin different from control by transcription
is control of gene expression by chromatin different from control by transcription
factors (and what are its advantages)?<o:p></o:p></b></span></p>
factors (and what are its advantages)?<o:p></o:p></b></span></p>
-
 
-
<p class=MsoNormal><span style='font-family:Arial'><b><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></b></span></p>
 
<p class=MsoNormal><span style='font-family:Arial'><b>A. <span
<p class=MsoNormal><span style='font-family:Arial'><b>A. <span
Line 377: Line 181:
is a completely different level of gene expression control.<o:p></o:p></b></span></p>
is a completely different level of gene expression control.<o:p></o:p></b></span></p>
-
<ol style='margin-top:0in' start=1 type=1>
+
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo3;
-
<ul style='margin-top:0in' type=disc>
+
tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span
-
  <li class=MsoNormal style='mso-list:l0 level2 lfo1;tab-stops:list 1.0in'><span
+
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
-
      style='font-family:Arial'>Dominant over transcription factors (resistant
+
</span></span><![endif]>Dominant over transcription factors (resistant to
-
      to noise).<o:p></o:p></span></li>
+
noise).</p>
-
  <li class=MsoNormal style='mso-list:l0 level2 lfo1;tab-stops:list 1.0in'><span
+
 
-
      style='font-family:Arial'>Regional &#8211; silences domains, not
+
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo3;
-
      individual genes (reduces the engineering required for regulation of
+
tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span
-
      complex multi-gene systems).<o:p></o:p></span></li>
+
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
-
  <li class=MsoNormal style='mso-list:l0 level2 lfo1;tab-stops:list 1.0in'><span
+
</span></span><![endif]>Regional &#8211; silences domains, not individual genes
-
      style='font-family:Arial'>Memory&#8211;Alteration in gene expression
+
(reduces the engineering required for regulation of complex multi-gene
-
      lasts for multiple generations (epigenetic control).<o:p></o:p></span></li>
+
systems).</p>
-
  <li class=MsoNormal style='mso-list:l0 level2 lfo1;tab-stops:list 1.0in'><span
+
 
-
      style='font-family:Arial'>Intrinsically bistable, i.e. all-or-none
+
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo3;
-
      expression (increases parameter space over which circuits are predicted
+
tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span
-
      to be stable).<o:p></o:p></span></li>
+
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
-
</ul>
+
</span></span><![endif]>Memory&#8211;Alteration in gene expression lasts for
-
</ol>
+
multiple generations (epigenetic control).</p>
 +
 
 +
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo3;
 +
tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span
 +
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
 +
</span></span><![endif]>Intrinsically bistable, i.e. all-or-none expression
 +
(increases parameter space over which circuits are predicted to be stable).</p>
<p class=MsoNormal><span style='font-family:Arial'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>
<p class=MsoNormal><span style='font-family:Arial'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>
Line 404: Line 214:
applications could this type of synthetic chromatin control system be used for?<o:p></o:p></b></span></p>
applications could this type of synthetic chromatin control system be used for?<o:p></o:p></b></span></p>
-
<p class=MsoNormal style='text-indent:.25in'><span style='font-family:Arial'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>
+
<p class=MsoNormal><span style='font-family:Arial'><b>A. <span
 +
style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>To
 +
stably and permanently switch cells between different states characterized by significant differences in gene expression (i.e. cellular differentiation).<o:p></o:p></b></span></p>
-
<p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><span
+
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l2 level2 lfo5;
-
style='font-family:Arial'><b>A. <span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>To
+
tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span
-
stably and permanently switch cells between different states characterized by significant
+
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
-
differences in gene expression (i.e. cellular differentiation).<o:p></o:p></b></span></p>
+
</span></span><![endif]>In bio-production&#8211;for coordinated switching
 +
between a growth phase and a production phase.</p>
-
<p class=MsoNormal style='margin-left:1.0in;text-indent:-.25in;mso-list:l2 level2 lfo8;
+
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l3 level1 lfo7;
tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span
tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
-
</span></span><![endif]><span style='font-family:Arial'>In bio-production&#8211;for
+
</span></span><![endif]>In bio-production&#8211;to differentiate a clonal
-
coordinated switching between a growth phase and a production phase.<o:p></o:p></span></p>
+
population of cells into a distribution of subtypes that function cooperatively
 +
(“factory” with different specialized “workers”).</p>
-
<p class=MsoNormal style='margin-left:1.0in;text-indent:-.25in;mso-list:l7 level1 lfo6;
+
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo3;
tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span
tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
-
</span></span><![endif]><span style='font-family:Arial'>In bio-production&#8211;to
+
</span></span><![endif]>To reprogram cell fate in a highly specific manner
-
differentiate a clonal population of cells into a distribution of subtypes that
+
(e.g. stem cell engineering, correction of epigenetic abnormalities in cancer
-
function cooperatively (“factory” with different specialized “workers”).<o:p></o:p></span></p>
+
cells).</p>
-
<ol style='margin-top:0in' start=1 type=1>
+
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo3;
-
<ul style='margin-top:0in' type=disc>
+
tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span
-
  <li class=MsoNormal style='mso-list:l0 level2 lfo1;tab-stops:list 1.0in'><span
+
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
-
      style='font-family:Arial'>To reprogram cell fate in a highly specific
+
</span></span><![endif]>To create cells with highly digital computational
-
      manner (e.g. stem cell engineering, correction of epigenetic abnormalities
+
capabilities.</p>
-
      in cancer cells).<o:p></o:p></span></li>
+
 
-
  <li class=MsoNormal style='mso-list:l0 level2 lfo1;tab-stops:list 1.0in'><span
+
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo3;
-
      style='font-family:Arial'>To create cells with highly digital
+
tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span
-
      computational capabilities.<o:p></o:p></span></li>
+
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
-
  <li class=MsoNormal style='mso-list:l0 level2 lfo1;tab-stops:list 1.0in'><span
+
</span></span><![endif]>To study chromatin spreading mechanism in a
-
      style='font-family:Arial'>To study chromatin spreading mechanism in a
+
quantitative and controlled way.</p>
-
      quantitative and controlled way.<o:p></o:p></span></li>
+
-
</ul>
+
-
</ol>
+
<p class=MsoNormal style='margin-left:.25in'><span style='font-family:Arial'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>
<p class=MsoNormal style='margin-left:.25in'><span style='font-family:Arial'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>
Line 443: Line 254:
<p class=MsoNormal style='margin-left:.25in'><span style='font-family:Arial'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>
<p class=MsoNormal style='margin-left:.25in'><span style='font-family:Arial'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>
-
<ol style='margin-top:0in' start=2 type=1>
+
<p class=MsoNormal><span style='font-family:Arial'><b>Q. <span
-
<li class=MsoNormal style='mso-list:l0 level1 lfo1;tab-stops:list .5in'><span
+
style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Could
-
    style='font-family:Arial'><b>Could this type of yeast synthetic chromatin
+
this type of yeast synthetic chromatin control system be utilized in other cell
-
    control system be utilized in other cell types, including mammalian cells?<o:p></o:p></b></span></li>
+
types, including mammalian cells?<o:p></o:p></b></span></p>
-
<ul style='margin-top:0in' type=disc>
+
 
-
  <li class=MsoNormal style='mso-list:l0 level2 lfo1;tab-stops:list 1.0in'><span
+
<p class=MsoNormal><span style='font-family:Arial'><b>A. <span
-
      style='font-family:Arial'>Core elements of this system are: initiator,
+
style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Yes,
-
      covalent mark, spreading (polymerization).<o:p></o:p></span></li>
+
the approach should be transferable.<o:p></o:p></b></span></p>
-
  <li class=MsoNormal style='mso-list:l0 level2 lfo1;tab-stops:list 1.0in'><span
+
 
-
      style='font-family:Arial'>In <i>S. cerevisiae</i></span><span
+
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo3;
-
      style='font-family:Arial'>, covalent mark is deacetylation&#8211;we use
+
tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span
-
      an initiator (LexA-Sir2) that when localized deacetylates adjacent
+
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
-
      histones.<span style="mso-spacerun: yes">&nbsp; </span>This leads to
+
</span></span><![endif]>Core elements of this system are: initiator, covalent
-
      further recruitment of Sir2, which propagates the mark outward.
+
mark, spreading (polymerization).</p>
-
      Deacetylated chromatin adopts a “closed” conformation. <o:p></o:p></span></li>
+
 
-
  <li class=MsoNormal style='mso-list:l0 level2 lfo1;tab-stops:list 1.0in'><span
+
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo3;
-
      style='font-family:Arial'>For higher eukaryotes, from <i>S. pombe</i></span><span
+
tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span
-
      style='font-family:Arial'> to human, the covalent mark is methylation,
+
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
-
      initiator is a histone methyltransferase. But in principle, a similar
+
</span></span><![endif]>In <i>S. cerevisiae</i><span style='font-style:normal'>,
-
      system should work.<span style="mso-spacerun: yes">&nbsp; </span>Same
+
covalent mark is deacetylation&#8211;we use an initiator (LexA-Sir2) that when
-
      logical design, with different catalytic functions propagating spread.<o:p></o:p></span></li>
+
localized deacetylates adjacent histones.<span style="mso-spacerun: yes">&nbsp;
-
</ul>
+
</span>This leads to further recruitment of Sir2, which propagates the mark
-
</ol>
+
outward. Deacetylated chromatin adopts a “closed” conformation. </span></p>
 +
 
 +
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo3;
 +
tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span
 +
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
 +
</span></span><![endif]>For higher eukaryotes, from <i>S. pombe</i><span
 +
style='font-style:normal'> to human, the covalent mark is methylation,
 +
initiator is a histone methyltransferase. But in principle, a similar system
 +
should work.<span style="mso-spacerun: yes">&nbsp; </span>Same logical design,
 +
with different catalytic functions propagating spread.</span></p>
<p class=MsoNormal><span style='font-family:Arial'><span style="mso-spacerun:
<p class=MsoNormal><span style='font-family:Arial'><span style="mso-spacerun:
Line 475: Line 295:
</html>
</html>
 +

Revision as of 00:16, 23 October 2008

Frequently asked questions (FAQs) on Synthetic Chromatin

Q.         How is control of gene expression by chromatin different from control by transcription factors (and what are its advantages)?

A.          Chromatin is a completely different level of gene expression control.

·        Dominant over transcription factors (resistant to noise).

·        Regional – silences domains, not individual genes (reduces the engineering required for regulation of complex multi-gene systems).

·        Memory–Alteration in gene expression lasts for multiple generations (epigenetic control).

·        Intrinsically bistable, i.e. all-or-none expression (increases parameter space over which circuits are predicted to be stable).

 

 

Q.         What applications could this type of synthetic chromatin control system be used for?

A.          To stably and permanently switch cells between different states characterized by significant differences in gene expression (i.e. cellular differentiation).

·        In bio-production–for coordinated switching between a growth phase and a production phase.

·        In bio-production–to differentiate a clonal population of cells into a distribution of subtypes that function cooperatively (“factory” with different specialized “workers”).

·        To reprogram cell fate in a highly specific manner (e.g. stem cell engineering, correction of epigenetic abnormalities in cancer cells).

·        To create cells with highly digital computational capabilities.

·        To study chromatin spreading mechanism in a quantitative and controlled way.

 

 

Q.         Could this type of yeast synthetic chromatin control system be utilized in other cell types, including mammalian cells?

A.          Yes, the approach should be transferable.

·        Core elements of this system are: initiator, covalent mark, spreading (polymerization).

·        In S. cerevisiae, covalent mark is deacetylation–we use an initiator (LexA-Sir2) that when localized deacetylates adjacent histones.  This leads to further recruitment of Sir2, which propagates the mark outward. Deacetylated chromatin adopts a “closed” conformation.

·        For higher eukaryotes, from S. pombe to human, the covalent mark is methylation, initiator is a histone methyltransferase. But in principle, a similar system should work.  Same logical design, with different catalytic functions propagating spread.

 



Home The Team The Project Parts Submitted to the Registry Modeling Human Practices Notebooks